Delayed death in burns and the allegations of medical negligence

Burns : Journal of the International Society for Burn Injuries
B R Sharma

Abstract

Burns and deaths due to burns to remain an important public health and social problem in India. Most of the victims, who survive the initial 24h after burns, succumb to infection of the burnt area and its complications. Burns cause devitalization of tissues, leaving extensive raw areas, which usually remain moist due to the outflow of serous exudate. This exposed, moist area along with the dead and devitalized tissue provides the optimum environment favoring colonization and proliferation of numerous microorganisms, which is further enhanced by the depression of the immune response. All these factors, i.e., disruption of the skin barrier, a large cutaneous bacterial load, the possibility of the normal bacterial flora turning into opportunistic pathogens and the severe depression of the immune system, contribute towards sepsis in a burns victim, which usually is life threatening. Despite various advances in infection control measures, early detection of microorganisms and newer, broader spectrum antibiotics, management of burn septicemia still remains a challenge. Pulmonary, cardiac and other complications also contribute to the delayed deaths following severe burn.

References

Sep 1, 1992·The Journal of Burn Care & Rehabilitation·R B FratianneT Coffee
Oct 1, 1987·Annals of Plastic Surgery·G D MukherjeeM Seal
Jan 1, 1986·The International Journal of Social Psychiatry·D R Adityanjee
Dec 1, 1970·The Journal of Trauma·Z Janzekovic
Oct 1, 1971·American Journal of Surgery·A M MunsterB A Pruitt
Feb 1, 1983·The Journal of Trauma·W G Marshall, A R Dimick
Apr 1, 1995·Journal of Pediatric Surgery·M J GoretskyB W Warner
Aug 1, 1993·Annals of Surgery·J C MarshallJ L Meakins
Feb 6, 1998·World Journal of Surgery·B A PruittC W Goodwin
Jan 19, 1999·Archives of Internal Medicine·T Kahn
Mar 10, 2000·Archives of Pediatrics & Adolescent Medicine·R L SheridanR G Tompkins
Feb 7, 2001·BMJ : British Medical Journal·J Siegel-Itzkovich
Apr 18, 2000·Critical Care Clinics·A KumarJ E Parrillo
Mar 26, 2002·Critical Care Clinics·Rachel G Khadaroo, John C Marshall
Sep 11, 2002·Burns : Journal of the International Society for Burn Injuries·Mohammed K EbrahimRameshwar L Bang
Mar 28, 2003·Lancet·Marcus SpiesSteven E Wolf
Apr 23, 2003·Burns : Journal of the International Society for Burn Injuries·Salah NasserAshraf Maher
Apr 23, 2003·Burns : Journal of the International Society for Burn Injuries·Anil K Batra
Jun 5, 2003·Burns : Journal of the International Society for Burn Injuries·Tzyy-Jiin ChenRong-Hwang Fang
Oct 15, 2003·Burns : Journal of the International Society for Burn Injuries·Alastair P BrownStephen Sinclair
Mar 17, 2004·Burns : Journal of the International Society for Burn Injuries·R B AhujaG R Sethi
Nov 24, 2004·Burns : Journal of the International Society for Burn Injuries·Joan WeberUNKNOWN Nursing Committee of the International Society for Burn Injuries

❮ Previous
Next ❯

Citations

Feb 11, 2011·The Journal of Trauma·Ana Filipa Bastos Pedrosa, Acácio Gonçalves Rodrigues
Jun 10, 2008·Burns : Journal of the International Society for Burn Injuries·G C BloemsmaI M M H Oen
Sep 11, 2007·Infectious Disease Clinics of North America·B R Sharma
Nov 7, 2006·Burns : Journal of the International Society for Burn Injuries·A J K Patel
Oct 31, 2019·Antibiotics·Lucia TattoliBiagio Solarino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Burns : Journal of the International Society for Burn Injuries
Clifford PereiraDavid N Herndon
Journal of Burn Care & Research : Official Publication of the American Burn Association
Sidney F MillerJohn A Krichbaum
© 2021 Meta ULC. All rights reserved